The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 18, 2017

Filed:

Sep. 05, 2012
Applicants:

Mantu Bhuyan, Jorhat, IN;

Pranab Ram Bhattacharyya, Jorhat, IN;

Pranab Kumar Baruah, Jorhat, IN;

Nabin Chandra Barua, Jorhat, IN;

Paruchuri G. Rao, Jorhat, IN;

Sushmita Bhattacharya, Santiniketan, IN;

Rakesh Kundu, Santiniketan, IN;

Priyajit Chatterjee, Santiniketan, IN;

Soma Seal, Santiniketan, IN;

Sandeep Mukherjee, Santiniketan, IN;

Suman Dasgupta, Santiniketan, IN;

Sudipta Moitra, Santiniketan, IN;

Shelley Bhattacharya, Santiniketan, IN;

Samir Bhattacharya, Santiniketan, IN;

Inventors:

Mantu Bhuyan, Jorhat, IN;

Pranab Ram Bhattacharyya, Jorhat, IN;

Pranab Kumar Baruah, Jorhat, IN;

Nabin Chandra Barua, Jorhat, IN;

Paruchuri G. Rao, Jorhat, IN;

Sushmita Bhattacharya, Santiniketan, IN;

Rakesh Kundu, Santiniketan, IN;

Priyajit Chatterjee, Santiniketan, IN;

Soma Seal, Santiniketan, IN;

Sandeep Mukherjee, Santiniketan, IN;

Suman Dasgupta, Santiniketan, IN;

Sudipta Moitra, Santiniketan, IN;

Shelley Bhattacharya, Santiniketan, IN;

Samir Bhattacharya, Santiniketan, IN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 31/00 (2006.01); A61K 31/045 (2006.01); A61K 36/54 (2006.01);
U.S. Cl.
CPC ...
A61K 31/045 (2013.01); A61K 36/54 (2013.01);
Abstract

The present invention relates to a synergistic pharmaceutical composition comprising Compound C2 (Neo-isopulegol), C3 (Iso-pulegol) and C4 (Citronellol) derived from herbal seed extract ofuseful for the treatment of lung cancer. The present invention also relates to the activity of compounds C2 or C3 or C4 either alone or in combination in killing of A549 lung cancer cells.


Find Patent Forward Citations

Loading…